Update shared on 14 Dec 2025
Fair value Decreased 7.93%Analysts have trimmed their price target on EVN by roughly 8 percent, from about $32.88 to $30.27. This reflects lower expected revenue growth, partially offset by a slightly higher profit margin outlook and a modestly lower future P/E multiple.
Valuation Changes
- Fair Value Estimate has fallen from €32.88 to €30.27, reflecting a moderate downward revision in intrinsic valuation.
- Discount Rate has risen slightly from 5.53 percent to 5.71 percent, indicating a modest increase in the required return or perceived risk.
- Revenue Growth has fallen significantly from 1.71 percent to 0.18 percent, pointing to much more subdued top line expectations.
- Net Profit Margin has risen modestly from 12.58 percent to 13.77 percent, suggesting better expected operational efficiency or cost control.
- Future P/E has declined from 15.24x to 13.48x, implying a lower valuation multiple applied to forward earnings.
Have other thoughts on EVN?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.